Novo Nordisk tumbles as Wegovy sales miss, trial setback overshadow raised outlook
Go back to Novo Nordisk tumbles as Wegovy sales miss, trial setback overshadow raised outlook| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1140.20 +24.50 (2.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1115.70 | 52 Week High | $88.16 | |||
| Open | $1142.20 | 52 Week Low | $67.88 | |||
| Day High | $1153.95 | P/E | 263.94 | |||
| Day Low | $1130.50 | EPS | $4.32 | |||
| Volume | 628,327 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 43.27 +0.20 (0.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.07 | 52 Week High | $59.00 | |||
| Open | $43.66 | 52 Week Low | $32.80 | |||
| Day High | $43.71 | P/E | N/A | |||
| Day Low | $43.07 | EPS | $0.00 | |||
| Volume | 2,499,706 | |||||
